Intracystic Injection of NanoPac® in Subjects With Mucinous Cystic Pancreatic Neoplasms

NCT03188991 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Mucinous-Cystic Neoplasm

Interventions

DRUG: NanoPac®

Sponsor

NanOlogy, LLC

Collaborators

[object Object]